Parathyroid hormone-related protein expression, in combination with nodal status, predicts bone metastasis and prognosis of breast cancer patients

Experimental and Therapeutic Medicine

Volumn 3, Issue 6, 2012, Pages 963-968

  Takagaki, Keiichi ^a   Takashima, Tsutomu ^a   Onoda, Naoyoshi ^a   Tezuka, Kenji ^a   Noda, Eiji ^a   Kawajiri, Hidemi ^a   Ishikawa, Tetsuro ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metastasis; Breast cancer; Lymph node metastasis; Parathyroid hormone related protein

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 84859454616     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.521     Document Type: Article

References (33)

1. Coleman RE: Skeletal complications of malignancy. Cancer 80: 1588-1594, 1997.
2. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593, 2002.
3. Yoneda T and Hiraga T: Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328: 679-687, 2005.
4. Suva LJ, Winslow GA, Wettenhall RE, etal: A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896, 1987.
5. Yin JJ, Selander K, Chirgwin JM, etal: TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103: 197-206, 1999.
6. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR and Brown EM: Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141: 4357-4364, 2000
7. Suda T, Takahashi N, Udagawa N Jimi E, Gillespie MT and Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357, 1999.
8. Rubens RD: Clinical aspects of bone metastases. In: Tumor Bone Diseases and Osteoporosis in Cancer Patients. Body JJ (ed). Marcel Dekker, Inc., Brussels, p85, 2000.
9. Southby J, Kissin MW, Danks JA, etal: Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res 50: 7710-7716, 1990.
10. Liapis H, Crouch EC, Grosso LE, Kitazawa S and Wick MR: Expression of parathyroidlike protein in normal, proliferative, and neoplastic human breast tissues. Am J Pathol 143: 1169-1178, 1993.
11. Kohno N, Kitazawa S, Fukase M, etal: The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases. Surg Today 24: 215-220, 1994.
12. Downey SE, Hoyland J, Freemont AJ, Knox F, Walls J and Bundred NJ: Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue. JPathol183: 212-217, 1997.
13. Henderson M, Danks J, Moseley J, etal: Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J Natl Cancer Inst 93: 234-237, 2001.
14. Linforth R, Anderson N, Hoey R, etal: Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival. Clin Cancer Res 8: 3172-3177, 2002.
15. Surowiak P, Dziegiel P, Matkowski R, Sopel M, Wojnar A, Kornafel J and Zabel M: Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course. Virchows Arch 442: 245-251, 2003.
16. Fleming NI, Trivett MK, George J, etal: Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ. Cancer Res 69: 7473-7479, 2009.
17. Bouizar Z, Spyratos F, Deytieux S, de Vernejoul MC and Jullienne A: Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastasis. Cancer Res 53: 5076-5078, 1993.
18. Powell GJ, Southby J, Danks JA, etal: Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059-3061, 1991.
19. Kohno N, Kitazawa S, Sakoda Y, Kanbara Y, Furuya Y, Ohashi O and Kitazawa R: Parathyroid hormone-related protein in breast cancer tissues: relationship between primary and metastatic sites. Breast Cancer 1: 43-49, 1994.
20. Guise TA, Yin JJ, Taylor SD, etal: Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98: 1544-1549, 1996.
21. Thomas RJ, Guise TA, Yin JJ, Elliot J, Horwood NJ, Martin TJ and Gillespie MT: Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140: 4451-4458, 1999.
22. Tezuka K, Onoda N, Takashima T, Ishikawa T, Wakasa T, Wakasa K and Hirakawa K: Clinical significance of intra-tumoral sinusoidal structures showing lympho-endothelial immunoreactivity in breast cancer. Oncol Rep 20: 25-32, 2008.
23. Henderson MA, Danks JA, Slavin JL, etal: Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res 66: 2250-2256, 2006.
24. Torricelli C, Fortino V, Capurro E, etal: Role of PTHrp and PTHrp-engaged pathways in MCF-7cells migration/invasion. Matrix Biol 25: 104-111, 2006.
25. Dittmer A, Vetter M, Schunke D, Span PN, Sweep F, Thomssen C and Dittmer J: Parathyroid hormone-related protein regulates tumor-relevant genes in breast cancer cells. J Biol Chem 281: 14563-14572, 2006.
26. Braun S, Vogl FD, Naume B, etal: A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353: 793-802, 2005.
27. Wulf GG, Jürgens B, Liersch T, etal: Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer. J Cancer Res Clin Oncol 123: 514-521, 1997.
28. Guise TA, Kozlow WM, Heras-Herzig A, Padalecki SS, Yin JJ and Cirgwin JM: Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer 5 (Suppl 2): 46-53, 2005.
29. Russell RG, Rogers MJ, Frith JC, etal: The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res 14 (Suppl 2): 53-65, 1999.
30. Gnant M: Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials. Curr Cancer Drug Targets 9: 824-833, 2009.
31. Aft R, Naughton M, Trinkaus K, etal: Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2trial. Lancet Oncol 11: 421-428, 2010.
32. Saito H, Tsunenari T, Onuma E, Sato K, Ogata E and Yamada-Okabe H: Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231. Anticancer Res 25: 3817-3824, 2005.
33. Body JJ, Facon T, Coleman RE, etal: A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Clin Cancer Res 12: 1221-1228, 2006.